The University of Chicago Header Logo

Connection

Peter O'Donnell to Chemotherapy, Adjuvant

Back to Details
This is a "connection" page, showing publications Peter O'Donnell has written about Chemotherapy, Adjuvant.
Peter O'Donnell
Connection Strength
0.170
Chemotherapy, Adjuvant
  1. Editorial comment. Urology. 2011 Jan; 77(1):165-6.
    View in: PubMed
    Score: 0.072
  2. Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med. 2026 Apr 02; 394(13):1257-1269.
    View in: PubMed
    Score: 0.051
  3. Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer. J Oncol Pharm Pract. 2026 Jan; 32(1):62-70.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.